Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cerami

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Parkinsonism & Related Disorders|July 31, 2012
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's diseaseS Iannaccone, C Cerami, M Alessio, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injuryM L Brines, P Ghezzi, S Keenan, et al.
Journal of the Neurological Sciences|March 16, 2015
Motor neuron dysfunctions in the frontotemporal lobar degeneration spectrum: a clinical and neurophysiological studyC Cerami, A Marcone, C Crespi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Tobacco smoke is a source of toxic reactive glycation productsC Cerami, H Founds, I Nicholl, et al.
Ebiomedicine|November 18, 2016
Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron SupplementationM M Goheen, R Wegmüller, A Bah, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 13, 2011
White matter damage in frontotemporal lobar degeneration spectrumF Agosta, E Scola, E Canu, et al.
Parkinsonism & Related Disorders|May 8, 2025
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarkerM Avenali, S P Caminiti, M Gegg, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2023
Is There More than One Erythropoietin Receptor? Can the Hematopoietic Effects of EPO Be Dissociated from the Organ-Protective Effects by Carbamylated Erythropoietin?: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242, 2004M Leist, P Ghezzi, G Grasso, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Parkinsonism & Related Disorders|July 31, 2012
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's diseaseS Iannaccone, C Cerami, M Alessio, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 14, 2000
Erythropoietin crosses the blood-brain barrier to protect against experimental brain injuryM L Brines, P Ghezzi, S Keenan, et al.
Journal of the Neurological Sciences|March 16, 2015
Motor neuron dysfunctions in the frontotemporal lobar degeneration spectrum: a clinical and neurophysiological studyC Cerami, A Marcone, C Crespi, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 12, 1998
Tobacco smoke is a source of toxic reactive glycation productsC Cerami, H Founds, I Nicholl, et al.
Ebiomedicine|November 18, 2016
Anemia Offers Stronger Protection Than Sickle Cell Trait Against the Erythrocytic Stage of Falciparum Malaria and This Protection Is Reversed by Iron SupplementationM M Goheen, R Wegmüller, A Bah, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 13, 2011
White matter damage in frontotemporal lobar degeneration spectrumF Agosta, E Scola, E Canu, et al.
Parkinsonism & Related Disorders|May 8, 2025
Combined assessment of blood glucocerebrosidase activity and α-synuclein levels in GBA1 mutation carriers: A novel potential biomarkerM Avenali, S P Caminiti, M Gegg, et al.
Journal of the American Society of Nephrology : JASN|March 30, 2023
Is There More than One Erythropoietin Receptor? Can the Hematopoietic Effects of EPO Be Dissociated from the Organ-Protective Effects by Carbamylated Erythropoietin?: Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305: 239-242, 2004M Leist, P Ghezzi, G Grasso, et al.
Pageof 2